they bought a biotech company based in china with hep b treatment which has gone through phase III tirals there, ready to market
you could never market it in the west without going through western standard clinical trials but it's good enough for the chinese and se asia - which by the way, the hep b market is huge for!
you should attribute no value to the thrombo rubbish - it's got nothing
plus on top of all that, the chart had the juciest techinical run-up out of a descending wedge
maybe it's the new way for pharma companies?? just put it through chinese standards and sell to asia, excuse the cynicism
- Forums
- ASX - By Stock
- CT1
- re agx
re agx, page-10
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CT1 (ASX) to my watchlist
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.212M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
34 | 26292570 | 0.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.2¢ | 3434691 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
34 | 26292570 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.002 | 3434691 | 4 |
0.003 | 5576334 | 8 |
0.004 | 46344996 | 8 |
0.005 | 42000000 | 3 |
0.007 | 2500000 | 2 |
Last trade - 16.12pm 14/08/2024 (20 minute delay) ? |
Featured News
CT1 (ASX) Chart |
Day chart unavailable